To delineate broad gene expression changes common to the uptake of disease associated tau aggregates, bulk RNA-seq data from astrocytes treated with tau from AD cases or control brain extracts were grouped and compared to untreated astrocytes. Here, MAPT is linked to Alzheimer disease.